drug protocol number

CRAD001H2307

drug sponsor

Novartis

drug study

Everolimus / reduced tacrolimus / Tacrolimus

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase